Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 25, 2025

Cannabidiol improves short-term memory in a Streptozotocin-induced animal model of Alzheimer’s disease

View Full Paper
Ask AI
Bookmark
Share

Authors

GPGabrielle Christine PereiraVSVanessa Lima do Nascimento SilvaBSBeatriz Soares‐Silva

Discussion

Loading...

Member takes

Overview

Experimental model shows cannabidiol improves cognitive function in Alzheimer's disease, indicating it may have neuroprotective benefits.

Key Points

  • CBD treatment significantly improved short-term memory in rats with Alzheimer's disease.
  • Streptozotocin induced cognitive deficits and increased amyloid-beta levels in treated animals.
  • Wistar rats received CBD over 14 days, demonstrating its potential neuroprotective effects.
  • Findings support cannabidiol's role as a candidate for treating neurodegenerative diseases.

Cite This Study

Pereira et al. (2025) studied this question.

synapsesocial.com/papers/689a0627e6551bb0af8ce0f0https://doi.org/10.21203/rs.3.rs-7197783/v1
View Full Paper
Ask AI
Bookmark
Share